#Hyderabad-based Vaccine Manufacturer #BharatBiotech Said on Saturday That Its Trials for ... - Latest Tweet by IANS India
The latest Tweet by IANS India states, '#Hyderabad-based vaccine manufacturer #BharatBiotech said on Saturday that its trials for #Covaxin booster dose have shown 'long-term safety with no serious adverse events'.'
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)